Patents by Inventor John Edward Scharf

John Edward Scharf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11883177
    Abstract: Lactate threshold device (LTD) assists subjects in improving athletic performance and maximizing calorie burn. LTD digitizes the electrocardiogram (ECG) obtained from a chest belt with a first signal analyzer, and telemeters the ECG to a second signal analyzer. LTD uses a novel algorithm to convert the telemetered ECG from the time to frequency domain, utilizing a digital signal processing method called fast fourier transform based spectral analysis. LTD determines whether lactate threshold (LT) has been reached, and furthermore calculates heart rate, heart rate variability, and heart rate and power zones. LTD displays the determined variables on a local or remote display. Subject using LTD obtains feedback during a real-time exercise regimen in the field that has aerobic (below LT) and anaerobic (above LT) zones. By utilizing an exercise program with aerobic and anaerobic zones, both sprint and endurance fitness levels are improved, and weight loss potential is maximized.
    Type: Grant
    Filed: May 9, 2022
    Date of Patent: January 30, 2024
    Inventor: John Edward Scharf
  • Publication number: 20220265198
    Abstract: Lactate threshold device (LTD) assists subjects in improving athletic performance and maximizing calorie burn. LTD digitizes the electrocardiogram (ECG) obtained from a chest belt with a first signal analyzer, and telemeters the ECG to a second signal analyzer. LTD uses a novel algorithm to convert the telemetered ECG from the time to frequency domain, utilizing a digital signal processing method called fast fourier transform based spectral analysis. LTD determines whether lactate threshold (LT) has been reached, and furthermore calculates heart rate, heart rate variability, and heart rate and power zones. LTD displays the determined variables on a local or remote display. Subject using LTD obtains feedback during a real-time exercise regimen in the field that has aerobic (below LT) and anaerobic (above LT) zones. By utilizing an exercise program with aerobic and anaerobic zones, both sprint and endurance fitness levels are improved, and weight loss potential is maximized.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 25, 2022
    Inventor: John Edward Scharf
  • Patent number: 11331032
    Abstract: Lactate threshold device (LTD) assists subjects in improving athletic performance and maximizing calorie burn. LTD digitizes the electrocardiogram (ECG) obtained from a chest belt with a first signal analyzer, and telemeters the ECG to a second signal analyzer. LTD uses a novel algorithm to convert the telemetered ECG from the time to frequency domain, utilizing a digital signal processing method called fast fourier transform based spectral analysis. LTD determines whether lactate threshold (LT) has been reached, and furthermore calculates heart rate, heart rate variability, and heart rate and power zones. LTD displays the determined variables on a local or remote display. Subject using LTD obtains feedback during a real-time exercise regimen in the field that has aerobic (below LT) and anaerobic (above LT) zones. By utilizing an exercise program with aerobic and anaerobic zones, both sprint and endurance fitness levels are improved, and weight loss potential is maximized.
    Type: Grant
    Filed: July 13, 2019
    Date of Patent: May 17, 2022
    Inventor: John Edward Scharf
  • Publication number: 20210007619
    Abstract: Lactate threshold device (LTD) assists subjects in improving athletic performance and maximizing calorie burn. LTD digitizes the electrocardiogram (ECG) obtained from a chest belt with a first signal analyzer, and telemeters the ECG to a second signal analyzer. LTD uses a novel algorithm to convert the telemetered ECG from the time to frequency domain, utilizing a digital signal processing method called fast fourier transform based spectral analysis. LTD determines whether lactate threshold (LT) has been reached, and furthermore calculates heart rate, heart rate variability, and heart rate and power zones. LTD displays the determined variables on a local or remote display. Subject using LTD obtains feedback during a real-time exercise regimen in the field that has aerobic (below LT) and anaerobic (above LT) zones. By utilizing an exercise program with aerobic and anaerobic zones, both sprint and endurance fitness levels are improved, and weight loss potential is maximized.
    Type: Application
    Filed: July 13, 2019
    Publication date: January 14, 2021
    Inventor: John Edward Scharf
  • Patent number: 6496711
    Abstract: A diagnostic instrument for determining a cardiovascular system parameter. In one embodiment, the instrument takes the form of a portable pulse oximeter comprising a light to frequency converter (LFC) as a sensor. Also provided is a light to frequency converter comprising a photoresistor and capacitor in circuit communication with an inverting Schmitt trigger and configured such that the inverter generates a periodic electrical signal corresponding to the amount of electromagnetic radiation illuminating the photoresistor.
    Type: Grant
    Filed: January 3, 2000
    Date of Patent: December 17, 2002
    Assignee: University of Florida
    Inventors: Stephan Peter Athan, John Edward Scharf
  • Patent number: 6330468
    Abstract: A reflectance pulse oximeter that determines oxygen saturation of hemoglobin using two sources of electromagnetic radiation in the green optical region, which provides the maximum reflectance pulsation spectrum. The use of green light allows placement of an oximetry probe at central body sites (e.g., wrist, thigh, abdomen, forehead, scalp, and back). Preferably, the two green light sources alternately emit light at 560 nm and 577 nm, respectively, which gives the biggest difference in hemoglobin extinction coefficients between deoxyhemoglobin, RHb, and oxyhemoglobin, HbO2.
    Type: Grant
    Filed: November 3, 1998
    Date of Patent: December 11, 2001
    Assignee: University of South Florida
    Inventor: John Edward Scharf
  • Patent number: 6011985
    Abstract: A diagnostic instrument for determining a cardiovascular system parameter. In one embodiment, the instrument takes the form of a portable pulse oximeter comprising a light to frequency converter (LFC) as a sensor. Also provided is a light to frequency converter comprising a photoresistor and capacitor in circuit communication with an inverting Schmitt trigger and configured such that the inverter generates a periodic electrical signal corresponding to the amount of electromagnetic radiation illuminating the photoresistor.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: January 4, 2000
    Assignee: University of South Florida
    Inventors: Stephan Peter Athan, John Edward Scharf
  • Patent number: 5830137
    Abstract: A reflectance pulse oximeter that determines oxygen saturation of hemoglobin using two sources of electromagnetic radiation in the green optical region, which provides the maximum reflectance pulsation spectrum. The use of green light allows placement of an oximetry probe at central body sites (e.g., wrist, thigh, abdomen, forehead, scalp, and back). Preferably, the two green light sources alternately emit light at 560 nm and 577 nm, respectively, which gives the biggest difference in hemoglobin extinction coefficients between deoxyhemoglobin, RHb, and oxyhemoglobin, HbO.sub.2.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: November 3, 1998
    Assignee: University of South Florida
    Inventor: John Edward Scharf